Human biomonitoring as a pragmatic tool to support health risk management of chemicals - Examples under the EU REACH programme

Regulatory Toxicology and Pharmacology

Volumn 59, Issue 1, 2011, Pages 125-132

  Boogaard, Peter J ^a   Hays, Sean M ^b   Aylward, Lesa L ^b  

^a SHELL GLOBAL SOLUTIONS INTERNATIONAL B V   (United States)

^b LLP   (United States)

Author keywords

Biomonitoring; Biomonitoring Equivalent; DNEL; REACH; Risk assessment; Risk management

Indexed keywords

1,1,1 TRICHLOROETHANE; 4,4' ISOPROPYLIDENEDIPHENOL; TOLUENE; TRICLOSAN;

ARTICLE; BIOLOGICAL MONITORING; BODY WEIGHT; DIETARY INTAKE; DOSE RESPONSE; ENVIRONMENTAL PROTECTION; HEALTH HAZARD; HUMAN; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK MANAGEMENT; RISK REDUCTION; STEADY STATE;

ANIMALS; BIOLOGICAL MARKERS; BODY BURDEN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; EUROPEAN UNION; HUMANS; NO-OBSERVED-ADVERSE-EFFECT LEVEL; PHENOLS; PROGRAM DEVELOPMENT; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TOLUENE; TOXICOLOGY; TRICHLOROETHANES; TRICLOSAN;

EID: 78751590989     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2010.09.015     Document Type: Article

References (60)

1. Allmyr M., et al. The influence of age and gender on triclosan concentrations in Australian human blood serum. Sci. Total Environ. 2008, 393:162-167.
2. Aylward L.L., Hays S.M. Biomonitoring Equivalents (BE) dossier for 2,4-dichlorophenoxyacetic acid (2,4-D) (CAS No. 94-75-7). Regul. Toxicol. Pharmacol. 2008, 51:S37-S48.
3. Aylward L.L., et al. Biomonitoring Equivalents (BE) dossier for toluene (CAS No. 108-88-3). Regul. Toxicol. Pharmacol. 2008, 51:S27-S36.
4. Aylward L.L., et al. Biomonitoring Equivalents (BE) dossier for trihalomethanes. Regul. Toxicol. Pharmacol. 2008, 51:S68-S77.
5. Aylward L.L., et al. Derivation of Biomonitoring Equivalent (BE) values for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds: a screening tool for interpretation of biomonitoring data in a risk assessment context. J Toxicol Environ Health A 2008, 71:1499-1508.
6. Aylward L.L., et al. Derivation of Biomonitoring Equivalents for di(2-ethylhexyl)phthalate (CAS No. 117-81-7). Regul. Toxicol. Pharmacol. 2009, 55:249-258.
7. Aylward L.L., et al. Derivation of Biomonitoring Equivalents for di-n-butyl phthalate (DBP), benzylbutyl phthalate (BzBP), and diethyl phthalate (DEP). Regul. Toxicol. Pharmacol. 2009, 55:259-267.
8. Aylward L.L., et al. Chemical-specific screening criteria for interpretation of biomonitoring data for volatile organic compounds (VOCs) - application of steady-state PBPK model solutions. Regul. Toxicol. Pharmacol. 2010, 58:33-44.
9. Aylward L.L., et al. Biomonitoring data for 2,4-dichlorophenoxyacetic acid in the United States and Canada: interpretation in a public health risk assessment context using Biomonitoring Equivalents. Environ. Health Perspect. 2010, 118:177-181.
10. Bartels M.J., Loizou G., Price P., Spendiff M., Arnold S., Cocker J., Ball N. Development of a tiered set of modelling tools for derivation of biomonitoring guidance values. Toxicol. Lett. 2009, 189(S1):154.
11. Bartels M.J., Loizou G., Price P., Rick D., Spendiff M., Arnold S., Cocker J., Ball N. Development of PK- and PBPK-based modelling tools for derivation of biomonitoring guidance values. Toxicol. Lett. 2010, 196(S):42.
12. Bartels, M., Loizou, G., Rick, D., Price, P., Spendiff, M., Arnold, S., Cocker, J., Ball, N., submitted for publication. Development of PK- and PBPK-based modeling tools for derivation of biomonitoring guidance values.
13. Boobis A.R., et al. IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit. Rev. Toxicol. 2006, 36:781-792.
14. Boobis A.R., et al. IPCS framework for analyzing the relevance of a noncancer mode of action for humans. Crit. Rev. Toxicol. 2008, 38:87-96.
15. Boogaard P.J. Biomonitoring of the Workplace and Environment. General and Applied Toxicology 2009, vol. 4:2559-2589. Wiley Chichester, UK. third ed.
16. Boogaard P.J., Money C.D. A proposed framework for the interpretation of biomonitoring data. Environ Health 2008, 7(Suppl. 1):S12.
17. Boogaard, P.J., Farmer, P.B., Knudsen, L.E., Onyon, L., Robison, S.H., Schoeters, G., Stropp, G.D., Wilks, M.F., Will, W., Holt, M., 2005. Guidance for the interpretation of biomonitoring data. ECETOC Document 44. ECETOC, Brussels.
18. Calafat A.M., Needham L.L. What additional factors beyond state-of-the-art analytical methods are needed for optimal generation and interpretation of biomonitoring data?. Environ. Health Perspect. 2009, 117:1481-1485.
19. CDC, 2008. National Report on Human Exposure to Environmental Chemicals (4th Report 2003-2004). Available from: http://www.cdc.gov/exposurereport/.
20. Chiu W.A., White P. Steady-state solutions to PBPK models and their applications to risk assessment I: route-to-route extrapolation of volatile chemicals. Risk Anal. 2006, 26:769-780.
21. EC, Council Regulation (EEC) No. 793/93 of 23 March 1993 on the evaluation and controls of existing substances, vol. 793/93, 1993.
22. EC, Commission decision of 12 July 1995 setting up a Scientific Committee for Occupational Exposure Limits to Chemical Agents (95/320/EC), vol. 95/320/EC, 1995.
23. EC, Regulation (EC) No. 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repairing Council Regulation (EEC) No. 793/93 and Commission Regulation (EC) No. 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC, vol. 1907/2006, 2006.
24. EC, Communication from the Commission on the reviews of Annexes I, IV and V to regulation (EC) No. 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation and Authorisation and Restriction of Chemicals (REACH) - Text with EEA relevance [SEC(2009)447], vol. C(2009)2482. Brussels, Commision of the European Communities, 8 April 2009, 2009.
25. ECETOC, 2010. Guidance on Assessment Factors to Derive DNELs. ECETOC Technical Report 110. ECETOC, Brussels.
26. ECHA, 2008. Guidance on information requirements and chemical safety assessment. Chapter R.8: characterisation of dose [concentration]-response for human health. European Chemicals Agency (ECHA), Helsinki. Available from: http://reach.jrc.it/docs/guidance_document/information_requirements_r8_en.pdf?vers=20_08_08.
27. Gade A.L., et al. Testing REACH draft technical guidance notes for conducting chemical safety assessments - the experience of a downstream user of a preparation. Regul. Toxicol. Pharmacol. 2008, 51:168-180.
28. Gebel T., et al. About hazard and risk assessment: regulatory approaches in assessing safety in the European Union chemicals legislation. Reprod. Toxicol. 2009, 28:188-195.
29. GerES, Health and Environmental Hygiene - German Environmental Survey (GerES). Available from: 2008. http://www.umweltbundesamt.de/gesundheit-e/survey/index.htm.
30. Harden F.A., et al. Evaluation of age, gender and regional concentration differences for dioxin-like chemicals in the Australian population. Chemosphere 2007, 67:S318-S324.
31. Hays S.M., Aylward L.L. Biomonitoring Equivalents (BE) dossier for acrylamide (AA) (CAS No. 79-06-1). Regul. Toxicol. Pharmacol. 2008, 51:S57-S67.
32. Hays S.M., Aylward L.L. Using Biomonitoring Equivalents to interpret human biomonitoring data in a public health risk context. J. Appl. Toxicol. 2009, 29:275-288.
33. Hays S.M., et al. Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective. Regul. Toxicol. Pharmacol. 2007, 47:96-109.
34. Hays S.M., et al. Biomonitoring Equivalents (BE) dossier for cadmium (Cd) (CAS No. 7440-43-9). Regul. Toxicol. Pharmacol. 2008, 51:S49-S56.
35. Huizer, D., Jongeneelen, F., Ten Berge, W., 2009. Use of a Generalized Toxicokinetic Model for the Prediction of Internal Dose for Occupational Exposure Assessment: The Example of Pyrene. Sixth International Conference on Innovations in Exposure Assessment (X2009), Cambridge, MA, 2009, pp. 9. Available from: http://www.x2009.org/.
36. IPCS, 1994. Assessing human health risks of chemicals: derivation of guidance values for health-based exposure limits. Environmental Health Criteria, No. 170. World Health Organisation, Geneva.
37. Jongeneelen, F., Ten Berge, W., submitted for publication. A generic, cross-chemical predictive PBTK-model with multiple entry routes running as application in MS-Excel; Design of the model and simulation of experimental observations. J. Exp Sc. Environ Epidemiol.
38. Karrman A., et al. Levels of 12 perfluorinated chemicals in pooled Australian serum, collected 2002-2003, in relation to age, gender, and region. Environ. Sci. Technol. 2006, 40:3742-3748.
39. Kolossa-Gehring M., et al. German environmental survey for children (GerES IV) - first results. Int. J. Hyg. Environ. Health 2007, 210:535-540.
40. Krishnan K., et al. Biomonitoring equivalents for triclosan. Regul. Toxicol. Pharmacol. 2010, 58:10-17.
41. Krishnan K., et al. Biomonitoring equivalents for bisphenol A (BPA). Regul. Toxicol. Pharmacol. 2010, 58:18-24.
42. LaKind J.S., et al. Guidelines for the communication of Biomonitoring Equivalents: report from the Biomonitoring Equivalents Expert Workshop. Regul. Toxicol. Pharmacol. 2008, 51:S16-S26.
43. Lipscomb J.C., Poet T.S. In vitro measurements of metabolism for application in pharmacokinetic modeling. Pharmacol. Ther. 2008, 118:82-103.
44. Mage D.T., et al. Estimating pesticide dose from urinary pesticide concentration data by creatinine correction in the Third National Health and Nutrition Examination Survey (NHANES-III). J. Expo. Anal. Environ. Epidemiol. 2004, 14:457-465.
45. Paustenbach D., Galbraith D. Biomonitoring: is body burden relevant to public health?. Regul. Toxicol. Pharmacol. 2006, 44:249-261.
46. Perucca J., et al. Sex difference in urine concentration across differing ages, sodium intake, and level of kidney disease. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 292:R700-R705.
47. Remer T., Fonteyn N., Alexy U., Berkemeyer S. Longitudinal examination of 24-h urinary iodine excretion in school children as a sensitive, hydration status-independent research tool for studying iodine status. Am. J. Clin. Nutr. 2006, 83(3):639-646.
48. Remer T., Neubert A., Maser-Gluth C. Anthropometry-based reference values for 24-h urinary creatinine excretion during growth and their use in endocrine and nutritional research. Am. J. Clin. Nutr. 2002, 75(3):561-569.
49. Renwick A.G. Data-derived safety factors for the evaluation of food additives and environmental contaminants. Food Addit. Contam. 1993, 10:275-305.
50. SCCP, 2009. Opinion on triclosan. European Commission, Directorate General for Health and Consumer Protection. Brussels.
51. Schäfer C., Dorn S.B., Jakupoglu C., Mostert V. OEL vs. DNEL or expert judgement vs. default factors - reference values under REACH exemplified by styrene. Toxicol. Lett. 2009, 189S:S270-S271.
52. Schulz C., et al. The german human biomonitoring commission. Int. J. Hyg. Environ. Health 2007, 210:373-382.
53. SCOEL, 1999. Methodology for the derivation of occupational exposure limits. Key documentation. EUR 19253, Luxembourg.
54. SCOEL, 1999. Recommendation from Scientific Committee on Occupational Exposure Limits for Toluene. In: 18216, E., (Ed.), vol. SCOEL/SUM/18-final.
55. Sexton K., Needham L.L., Pirkle J.L. Human biomonitoring for environmental chemicals. Am. Sci. 2004, 92:38-45.
56. Tardif R., et al. Physiologically-based pharmacokinetic modeling of a mixture of toluene and xylene in humans. Risk Anal. 1995, 15:335-342.
57. Toms L.M., et al. Polyfluoroalkyl chemicals in pooled blood serum from infants, children, and adults in Australia. Environ. Sci. Technol. 2009, 43:4194-4199.
58. Toms L.M., et al. Serum polybrominated diphenyl ether (PBDE) levels are higher in children (2-5 years of age) than in infants and adults. Environ. Health Perspect. 2009, 117:1461-1465.
59. Volkel W., et al. Quantitation of bisphenol A and bisphenol A glucuronide in biological samples by high performance liquid chromatography-tandem mass spectrometry. Drug Metab. Dispos. 2005, 33:1748-1757.
60. Volkel W., et al. Determination of free and total bisphenol A in human urine to assess daily uptake as a basis for a valid risk assessment. Toxicol. Lett. 2008, 179:155-162.